Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.2504 (7.75%) ($5.7640 - $6.7976) on Thu. May. 30, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.87% (three month average) | RSI | 39 | Latest Price | $6.2504(7.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -2.4% a day on average for past five trading days. | Weekly Trend | EYES declines -13.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UNG(6%) FIVG(5%) ICLN(5%) IFRA(5%) | Factors Impacting EYES price | EYES will decline at least -2.935% in a week (0% probabilities). BND(-8%) VCIT(-6%) LQD(-6%) XLP(-5%) TIP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.935% (StdDev 5.87%) | Hourly BBV | 0 () | Intraday Trend | 8.4% | | | |
|
1 - 5 Day Possible Target | $-14.91(-338.54%) | Resistance Level | $7.04 | 5 Day Moving Average | $5.82(7.4%) | 10 Day Moving Average | $6.34(-1.41%) | 20 Day Moving Average | $7.04(-11.22%) | To recent high | -31.5% | To recent low | 10.2% | Market Cap | $1.996b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |